Ototoxicity resulting from combined administration of cisplatin and gentamicin

Laryngoscope

Volumn 106, Issue 4, 1996, Pages 401-406

  Riggs, Landon C ^a   Brummett, Robert E ^b   Guitjens, Sydney K ^b   Matz, Gregory J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GENTAMICIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA POTENTIAL; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; GUINEA PIG; HAIR CELL; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACOUSTIC STIMULATION; ACTION POTENTIALS; ANIMALS; CISPLATIN; COCHLEAR MICROPHONIC POTENTIALS; COCHLEAR NERVE; DRUG SYNERGISM; FEMALE; GENTAMICINS; GUINEA PIGS; HAIR CELLS; PERILYMPH; RANDOM ALLOCATION; TIME FACTORS;

EID: 0029875766     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199604000-00003     Document Type: Article

References (18)

1. Kumin GD. Clinical nephrotoxicity of tobramycin and gentamicin: a prospective study. JAMA. 1980;244(16):1808-1810.
2. Smith CR, Lipsky JJ, Laskin UL, et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980;302(20):1106-1109.
3. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, et al. Renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer. 1977;39(4):1362-1371.
4. Bitran JD, Desser RK, Billings AA, et al. Acute nephrotoxicity following cis-dichlorodiammine-platinum. Cancer. 1982; 49(9):1784-1788.
5. Piel IJ, Meyer D, Perlia CP, et al. Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep. 1974;58:871-875.
6. Laurell G. Ototoxicity of the anticancer drug cisplatin: clinical and experimental aspects. Scand Audiol Suppl. 1991;33: 1-47.
7. Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. LARYNGOSCOPE. 1993;103 (suppl 59):1-52.
8. Matz GJ. Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am. 1993;26(5):705-712.
9. Curtin JP, Hoskins WJ, Rubin SC, et al. Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy. Gynecol Oncol. 1991;40:17-20.
10. Yu LC, Shaneyfelt T, Warner R, et al. The efficacy of ticarcillin-clavulanate and gentamicin as empiric treatment for febrile neutropenic pediatric patients with cancer. Pediatr Hematol Oncol. 1994;11(2):181-187.
11. Schweitzer VG, Hawkins JE, Lilly DJ, et al. Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. Otolaryngol Head Neck Surg. 1984;92(1):38-49.
12. Kohn S, Fradis M, Podoshin L, et al. Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. LARYNGOSCOPE. 1991;101:709-716.
13. Vernon JA, Meikle M. Electrophysiology of the cochlea. In: Thompson RF, Patterson MM, eds. Bioelectric Recording Techniques. New York: Academic Press; 1993;4:3-61.
14. Brummett RE, Himes D, Sain B, et al. A comparative study of the ototoxicity of tobramycin and gentamicin. Arch Otolaryngol. 1972;96:505-512.
15. Brummett RE, Fox KE, Bendrick TW, et al. Ototoxicity of tobramycin, gentamicin, amikacin, and sisomicin in the guinea pig. J Antimicrobial Chemother. 1978;4(suppl A): 73-83.
16. Komune S, Asakuma S, Snow JB. Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg. 1981;89:275-282.
17. Tange RA, Vuzevski VD. Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol. 1984;239:41-47.
18. Kohn S, Fradis M, Pratt H, et al. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. LARYNGOSCOPE. 1988;98:865-871.